Literature DB >> 25287448

Paradoxical cardiac and cerebral arterial gas embolus during percutaneous lead extraction in a patient with a patent foramen ovale.

Clare Arnott1, Keith Kelly2, Darren Wolfers3, Gregory Cranney2, Robert Giles2.   

Abstract

A 42 year-old man presented for elective percutaneous lead extraction for pacemaker redundancy. The procedure was performed supine under general anaesthesia via the right femoral vein and was complicated by acute inferior ST elevation and hypotension. Urgent transoesophageal echocardiogram showed inferior left ventricular hypokinesis, right ventricular impairment, a patent foramen ovale and air in the left ventricle. Coronary angiography demonstrated normal coronary arteries, the ST changes resolved and the leads were subsequently removed intact. Post-operatively the patient displayed nystagmus, was managed with hyperbaric oxygen therapy, and had complete resolution of his symptoms. An MRI brain confirmed an acute left cerebellar infarction, and a diagnosis of paradoxical air embolus to the coronary and cerebral circulations was made. This case illustrates the risks associated with paradoxical embolism in patients with PFOs undertaking percutaneous lead extractions. It also highlights the need for further consideration into techniques to avoid this complication in all high-risk percutaneous procedures. Crown
Copyright © 2014. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cerebral infarction; Hyperbaric oxygen therapy; Lead extraction; Myocardial infarction; Paradoxical embolus; Patent foramen ovale

Mesh:

Year:  2014        PMID: 25287448     DOI: 10.1016/j.hlc.2014.09.002

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  1 in total

1.  Paradoxical air embolism during percutaneous nephrolithotomy due to patent foramen ovale: Case report.

Authors:  Daljeet Chahal; Vladimir Ruzhynsky; Iain McAuley; Desmond Sweeney; Paul Sobkin; Michael Kinahan; Rich Gardiner; John Kinahan
Journal:  Can Urol Assoc J       Date:  2015-09-09       Impact factor: 1.862

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.